Defining the Impact of Adjuvant Therapy in Molecularly Defined Subsets of Gastrointestinal Stromal Tumor : From Lumping to Splitting.
Portland Veterans Affairs Health Care System, Portland, Oregon2Knight Cancer Institute, Oregon Health and Science University, Portland.
Michael C
MC
Heinrich
Knight Cancer Institute, Oregon Health and Science University, Portland.
Christopher L
CL
Corless
Dana-Farber Cancer Institute and Ludwig Center at Harvard Medical School, Boston, Massachusetts.
George D
GD
Demetri
D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D046152:Gastrointestinal Stromal Tumors; D006801:Humans; D000068877:Imatinib Mesylate; D009154:Mutation
D000068877:Imatinib Mesylate